Zomedica stock rises as prelim Q4 revenue soars, CEO eyes growth via acquisitions [Seeking Alpha]
Zomedica Corp. Common Shares (ZOM)
US:NYSE Investor Relations:
investors.zomedica.com
Company Research
Source: Seeking Alpha
Zomedica stock rises as prelim Q4 revenue soars, CEO eyes growth via acquisitionsFeb. 09, 2023 6:55 AM ETZomedica Corp. (ZOM)ZOM:CABy:RavikashSA News EditorCharnchaiZomedica (NYSE:~4%Q4 revenue is expected tobe about $6M to $6.2M, mainly due to an increase in PulseVet sales and the inclusion of the recently acquired Assisi products, the company added.Revenue for full year 2022 is expected to be about $18.6M to $18.9M, growing 354% to +361% Y/Y, primarily driven by a full year's worth of PulseVet sales and the inclusion of Assisi products.For full year 2022, gross margin is anticipated to be about 72%.Cash, cash equivalents, and available-for-sale securities are expected to be ~$156M as of Dec. 31, 2022, according to preliminary data.Outlook"We expect to continue to grow revenue as we launch new products in 2023, including the VetGuardian wireless vital signs monitor launched in early January, the TRUVIEWâ?¢ digital microscopy platform we plan to launch in the second quarter, and sever
Show less
Read more
Impact Snapshot
Event Time:
ZOM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZOM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZOM alerts
High impacting Zomedica Corp. Common Shares news events
Weekly update
A roundup of the hottest topics
ZOM
News
- Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET [Yahoo! Finance]Yahoo! Finance
- Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ETAccesswire
- Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform [Yahoo! Finance]Yahoo! Finance
- Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) PlatformAccesswire
- Zomedica Provides NYSE American Listing Update [Yahoo! Finance]Yahoo! Finance
ZOM
Earnings
- 8/10/23 - Miss
ZOM
Sec Filings
- 3/15/24 - Form 8-K
- 2/29/24 - Form 8-K
- 2/20/24 - Form DEFA14A
- ZOM's page on the SEC website